ChemicalBook >> CAS DataBase List >>β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
- CAS No.
- 2365156-60-9
- Chemical Name:
- β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
- Synonyms
- Bikagwe metabolite M15;Bictegravir Impurity 9;Bictegravir Metabolite;Ambrisentan Impurity 1-d3(Ambrisentan Racemate-d3);Bictegravir Metabolite M15Q: What is Bictegravir Metabolite M15 Q: What is the CAS Number of Bictegravir Metabolite M15;β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl;(2S,3S,4S,5R)-6-(((2R)-5,7-dioxo-2-propyl-8-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic ac;(2S,3S,4S,5R)-6-(((2R)-5,7-dioxo-2-propyl-8-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid;(2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
- CBNumber:
- CB99781284
- Molecular Formula:
- C27H26F3N3O11
- Molecular Weight:
- 625.51
- MDL Number:
- MOL File:
- 2365156-60-9.mol
Last updated:2022-12-21 16:56:50
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Properties
| Boiling point | 945.8±65.0 °C(Predicted) |
|---|---|
| Density | 1.75±0.1 g/cm3(Predicted) |
| pka | 2.76±0.70(Predicted) |
| FDA UNII | TD2G64J9XN |
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Preparation Products And Raw materials
Raw materials
Preparation Products
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl Suppliers
Global Suppliers ( 9)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 | 3003392093@yongstandards.com | China | 9995 | 55 |
| Guangzhou Jiuzhi Pharmaceutical Technology Co., Ltd. | 020-89854820 | sales@jzpharma.cn | China | 1550 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19935 | 58 |
| Shenzhen Roark Pharma-Tec Co., Ltd. | 13128912434 | 2880126944@qq.com | China | 3159 | 58 |
| ShenZhen H&D Pharmaceutical Technology Co., LTD | 18126517264 | 2850476883@qq.com | China | 7948 | 58 |
| Hubei Moco Chemical Co., Ltd. | 18627753421; 18627756402 | 3001051413@qq.com | China | 20010 | 58 |
| Hubei Rhema Reference Materials Technology Co., Ltd. | 15787879035 15787875101 | ydw9035@rmastandards.com | China | 9975 | 58 |
β-D-Glucopyranosiduronic acid, (2R,5S,13aR)-2,3,4,5,7,9,13,13a-octahydro-7,9-dioxo-10-[[[(2,4,6-trifluorophenyl)methyl]amino]carbonyl]-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl
Bictegravir Metabolite M15Q: What is
Bictegravir Metabolite M15 Q: What is the CAS Number of
Bictegravir Metabolite M15
Bictegravir Impurity 9
(2S,3S,4S,5R,6S)-6-(((2R,5S,13aR)-7,9-Dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazepin-8-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Bikagwe metabolite M15
Ambrisentan Impurity 1-d3(Ambrisentan Racemate-d3)
(2S,3S,4S,5R)-6-(((2R)-5,7-dioxo-2-propyl-8-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
(2S,3S,4S,5R)-6-(((2R)-5,7-dioxo-2-propyl-8-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazin-6-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic ac
Bictegravir Metabolite
2365156-60-9
C27H26F3N3O11




